11-63818529-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138471.3(SPINDOC):c.610G>A(p.Val204Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000794 in 1,611,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138471.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPINDOC | NM_138471.3 | c.610G>A | p.Val204Ile | missense_variant, splice_region_variant | 4/6 | ENST00000294244.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPINDOC | ENST00000294244.9 | c.610G>A | p.Val204Ile | missense_variant, splice_region_variant | 4/6 | 1 | NM_138471.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152068Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000928 AC: 23AN: 247874Hom.: 0 AF XY: 0.0000745 AC XY: 10AN XY: 134306
GnomAD4 exome AF: 0.0000487 AC: 71AN: 1459370Hom.: 0 Cov.: 35 AF XY: 0.0000496 AC XY: 36AN XY: 726024
GnomAD4 genome AF: 0.000375 AC: 57AN: 152186Hom.: 0 Cov.: 31 AF XY: 0.000390 AC XY: 29AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.610G>A (p.V204I) alteration is located in exon 4 (coding exon 4) of the C11orf84 gene. This alteration results from a G to A substitution at nucleotide position 610, causing the valine (V) at amino acid position 204 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at